Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a short talk with your doctor lower dementia risk?

NCT ID NCT07831616

NEW Prevention Sponsor: Fujian Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether primary care doctors can deliver a brief lifestyle intervention to older adults at risk of dementia. The trial enrolls 300 people aged 60 and older with elevated dementia risk scores. Doctors at community health centers provide the intervention, and the study tracks changes in lifestyle, motivation, and program adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a brief lifestyle intervention delivered by primary care physicians
What this could lead to
If it works, this could give primary care clinics a simple, low-cost way to help older adults lower their dementia risk.
What could go wrong
The trial measures lifestyle changes and motivation, not whether dementia cases actually drop. Lifestyle programs often struggle with long-term adherence, and results in one health system may not transfer to others.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 60 years * CAIDE dementia risk score ≥ 6 * Possessing basic comprehension and verbal expression abilities * Voluntarily participating in the study and signing the informed consent form * Not participating in other clinical trials during the intervention period. Exclusion Criteria: * Individuals already diagnosed with dementia * individuals with severe heart, liver, or kidney disease * individuals with severe chronic diseases and comorbidities (e.g., congestive heart failure, or hypertension or diabetes with severe complications) * individuals with severe visual or hearing impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Risk of dementia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.